Related Experiment Video
Updated: Jul 8, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use
Stephen M Setter1, Joshua J Neumiller, Melanie Johnson
1Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University/Elder Services, Spokane, Washington 99217-6131, USA. ssetter@smhca.org
Summary
The Mini-Cog is a valuable tool for pharmacists to screen for dementia in elderly patients. This rapid assessment aids in identifying cognitive impairment within community settings.
Area of Science:
- Gerontology
- Pharmacology
- Neurology
Background:
- Dementia in the elderly ambulatory population is often unrecognized.
- Early identification of cognitive impairment is crucial for timely intervention.
- Pharmacists play a key role in community healthcare and patient monitoring.
Purpose of the Study:
- To introduce consultant pharmacists to the Mini-Cog screening tool.
- To review the evidence supporting the Mini-Cog's validity in community settings.
- To highlight the utility of rapid dementia screening in primary care.
Main Methods:
- Literature search of MEDLINE and Web of Science databases (1990-2006).
- Inclusion of original research and review articles in English.
- Focus on studies evaluating the Mini-Cog for dementia screening.
Main Results:
- A growing body of literature supports the clinical use of the Mini-Cog.
- The Mini-Cog is effective in identifying potential cognitive impairment in ambulatory elderly patients.
- It serves as a valuable instrument for healthcare practitioners, including pharmacists.
Conclusions:
- The Mini-Cog offers pharmacists a simple and effective method for dementia screening.
- Applicable across various settings: assisted living, long-term care, and community-dwelling populations.
- Facilitates early detection and management of cognitive decline in older adults.
More Related Videos
Related Concept Videos
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

